TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12810768

Group type: EXPERIMENTAL
Intervention: Melissa officinalis extract (60 drops/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 10429571

Group type: EXPERIMENTAL
Intervention: Interauricular low‐intensity infrared laser therapy (0.89 nm, 7.6 J/cm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interauricular laser therapy
Number of subjects: 0
Study: 8850249

Group type: EXPERIMENTAL
Intervention: UVB irradiation (4 times the minimal erythema dose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no UVB irradiation)
Number of subjects: 19
Study: 2163421

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice a day
Number of subjects: 125

Group type: COMPARATOR
Intervention: Atenolol 50 mg once a day
Number of subjects: 125
Study: 348407

Group type: EXPERIMENTAL
Intervention: Moisturizing soap bar
Number of subjects: 0
Study: 31173451

Group type: EXPERIMENTAL
Intervention: Interactive voice response system (G2, n = 64)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Diabeo-BI app software (G3, n = 64)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard care (G1, n = 63)
Number of subjects: 191
Study: 28336107

Group type: EXPERIMENTAL
Intervention: Enriched enteral nutrition (EEN)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard enteral nutrition
Number of subjects: 99
Study: 25981908

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 310

Group type: COMPARATOR
Intervention: Standard oxygen therapy delivered through a face mask
Number of subjects: 310

Group type: COMPARATOR
Intervention: Noninvasive positive-pressure ventilation
Number of subjects: 310

Group type: COMPARATOR
Intervention: Noninvasive ventilation
Number of subjects: 310
Study: 24180712

Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg/kg bolus over 15 minutes, followed by 0.2 µg/kg/min infusion for 24 hours)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dobutamine (7.5 µg/kg/min infusion for 24 hours)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 25
Study: 21593355

Group type: EXPERIMENTAL
Intervention: Intensive dietary counseling to modify dietary intake according to current recommendations
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no dietary counseling)
Number of subjects: 90
Study: 19317193

Group type: EXPERIMENTAL
Intervention: 6% CHO (35.1 kJ/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12% CHO (70.2 kJ/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16918658

Group type: EXPERIMENTAL
Intervention: 0.2% levobupivacaine
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 0.2% bupivacaine
Number of subjects: 86

Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 86
Study: 15191587

Group type: EXPERIMENTAL
Intervention: IMZ implant system (two-stage cylinder type)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brånemark implant system (two-stage screw type)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ITI implant system (one-stage screw type)
Number of subjects: 30
Study: 10775816

Group type: EXPERIMENTAL
Intervention: Pre‐emptive therapy with ganciclovir
Number of subjects: 19

Group type: COMPARATOR
Intervention: Universal prophylaxis with ganciclovir (historical controls)
Number of subjects: 19
Study: 9185458

Group type: EXPERIMENTAL
Intervention: PGE1 (0.02 microgram kg‐1 min‐1)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (standard lidocaine infusion)
Number of subjects: 109
Study: 8454792

Group type: EXPERIMENTAL
Intervention: Symptom diary monitoring
Number of subjects: 40

Group type: COMPARATOR
Intervention: PEFR monitoring
Number of subjects: 40
Study: 3948546

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen therapy to raise PaO2 ≥ 60 mm Hg (group 1, n = 6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen therapy to raise PvO2 ≥ 36 mm Hg (group 2, n = 6)
Number of subjects: 12
Study: 31053468

Group type: EXPERIMENTAL
Intervention: Minimally invasive direct anterior approach (MIDA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Direct lateral approach (DLA)
Number of subjects: 164
Study: 28295425

Group type: EXPERIMENTAL
Intervention: 1 mg of atropine administered before deflation of the cryoballoon (trial group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Atropine administered after the onset of hemodynamic variation (control group)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Prophylactic atropine administration
Number of subjects: 25
Study: 25201758

Group type: EXPERIMENTAL
Intervention: Active group (patients chose route of administration)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group (physician decided route of administration)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group (sublingual immunotherapy)
Number of subjects: 307
Study: 23684449

Group type: EXPERIMENTAL
Intervention: Indomethacin (100mg)
Number of subjects: 50
Study: 21411832

Group type: EXPERIMENTAL
Intervention: 5 mg/kg caffeine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 mg/kg caffeine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19427990

Group type: EXPERIMENTAL
Intervention: AquaLase
Number of subjects: 50

Group type: COMPARATOR
Intervention: NeoSoniX
Number of subjects: 50
Study: 16522922

Group type: EXPERIMENTAL
Intervention: Calcium-fortified milk
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D-fortified milk
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group (no milk supplementation)
Number of subjects: 501
Study: 14680564

Group type: EXPERIMENTAL
Intervention: DTI navigation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Traditional navigation
Number of subjects: 49
Study: 11385214

Group type: EXPERIMENTAL
Intervention: Color Doppler sonography
Number of subjects: 158

Group type: COMPARATOR
Intervention: Selective intra-arterial angiography
Number of subjects: 158
Study: 9726671

Group type: EXPERIMENTAL
Intervention: Aciclovir (Zovirax) combined with prednisolone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Prednisolone alone (Control)
Number of subjects: 44
Study: 8067760

Group type: EXPERIMENTAL
Intervention: LY217896 (75 mg) once daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3056132

Group type: EXPERIMENTAL
Intervention: External cardiac pacing device
Number of subjects: 239

Group type: COMPARATOR
Intervention: Not paced (Control)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: External cardiac pacing device (in hypotensive bradycardia)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Not paced (Control) (in hypotensive bradycardia)
Number of subjects: 239
Study: 30583148

Group type: EXPERIMENTAL
Intervention: Valbenazine 40 mg/day
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Valbenazine 80 mg/day
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191

Group type: COMPARATOR
Intervention: Valbenazine and placebo
Number of subjects: 191
Study: 28291393

Group type: EXPERIMENTAL
Intervention: ABVD + INRT for ePET-positive patients
Number of subjects: 1950

Group type: COMPARATOR
Intervention: ABVD only for ePET-negative patients in the F group
Number of subjects: 1950

Group type: COMPARATOR
Intervention: ABVD only for ePET-negative patients in the U group
Number of subjects: 1950
Study: 25624754

Group type: EXPERIMENTAL
Intervention: BCI-based cognitive training (CT) program, 24 half-hour sessions over 8 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Waitlist control (no intervention for 8 weeks)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: BCI-based cognitive training (CT) program
Number of subjects: 39
Study: 23445135

Group type: EXPERIMENTAL
Intervention: Vaginal lactoferrin for 21 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 128
Study: 21333873

Group type: EXPERIMENTAL
Intervention: Microcoaxial cataract surgery (1.8 mm CCI)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Biaxial cataract surgery (1.2 to 1.4 mm trapezoidal CCI)
Number of subjects: 2
Study: 19847073

Group type: EXPERIMENTAL
Intervention: Memory training (e.g. memory skills training, imagery, method of loci)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active control conditions
Number of subjects: 24
Study: 16364599

Group type: EXPERIMENTAL
Intervention: BP230 ELISA
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: BP180 ELISA
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Combined BP230 and BP180 ELISA
Number of subjects: 239
Study: 15715291

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9890849

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide gas at graded concentrations (n = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravenous isosorbide dinitrate, 2.5 mg (n = 8)
Number of subjects: 16
Study: 8886349

Group type: EXPERIMENTAL
Intervention: Undernourished individuals
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Adequately nourished individuals
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Undernourished individuals with acceptable serum vitamin A levels
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Adequately nourished individuals with acceptable serum vitamin A levels
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Non-anemic individuals
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Goitrous subjects
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Non-goitrous subjects
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Vitamin A deficient subjects
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Non-vitamin A deficient subjects
Number of subjects: 3200
Study: 1852567

Group type: EXPERIMENTAL
Intervention: Dermapoints Massageroller
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active placebo massage
Number of subjects: 0
Study: 6367012

Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy (SGV)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Less than 20% initial reduction in PAOpg (SGV and PCV)
Number of subjects: 685

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 685
Study: 31964174

Group type: EXPERIMENTAL
Intervention: Multicomponent rehabilitation program (motivational interview, goal attainment process, guidance for safe walking, progressive home exercise program, physical activity counseling, standard care)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Multicomponent rehabilitation program
Number of subjects: 117
Study: 31250193

Group type: EXPERIMENTAL
Intervention: Immediate loading (group A, n=81)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Delayed loading (group B, n=78)
Number of subjects: 158
Study: 31065710

Group type: EXPERIMENTAL
Intervention: Initial brooding temperature at 36°C
Number of subjects: 360

Group type: COMPARATOR
Intervention: Initial brooding temperatures at 26, 28, 30, and 32°C
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Initial brooding temperatures at 26 or 36°C
Number of subjects: 360

Group type: COMPARATOR
Intervention: Initial brooding temperatures at 28 to 34°C
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Upper critical temperature for initial brooding
Number of subjects: 360
Study: 28301690

Group type: EXPERIMENTAL
Intervention: ATG-10 (10 mg/kg)
Number of subjects: 224

Group type: COMPARATOR
Intervention: ATG-6 (6 mg/kg)
Number of subjects: 224
Study: 25441486

Group type: EXPERIMENTAL
Intervention: 100 mg/day soy isoflavone supplementation
Number of subjects: 190

Group type: COMPARATOR
Intervention: 500 mg calcium carbonate (Control)
Number of subjects: 190
Study: 23064969

Group type: EXPERIMENTAL
Intervention: Cognitive adaptation training (CAT); specific adjustments made for Danish context, duration not specified.
Number of subjects: 0
Study: 21712524

Group type: EXPERIMENTAL
Intervention: Early PCI
Number of subjects: 197

Group type: COMPARATOR
Intervention: Delayed PCI
Number of subjects: 197
Study: 18663579

Group type: EXPERIMENTAL
Intervention: Microneedles (180 mum height)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Microneedles (280 mum height)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hypodermic needle (25‐G)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Microneedles (180 mum height) and (280 mum height)
Number of subjects: 12
Study: 16551310

Group type: EXPERIMENTAL
Intervention: Increased fluid intake by 1.5 L of water
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo medication (8 mL inactive syrup per day)
Number of subjects: 141
Study: 15621108

Group type: EXPERIMENTAL
Intervention: Triple dosing of basiliximab (3 doses: prior to transplantation, day 4, and day 21)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Two doses of basiliximab (prior to transplantation and day 4)
Number of subjects: 11
Study: 10752804

Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) 25 mg and glucose 5 g administered simultaneously
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (AMI patients)
Number of subjects: 12
Study: 8883420

Group type: EXPERIMENTAL
Intervention: STn linked to KLH with DETOX-B adjuvant, 100 micrograms, subcutaneous injection at weeks 0, 2, 5, and 9, with low-dose cyclophosphamide (CTX, 300 mg m-2) pretreatment.
Number of subjects: 23

Group type: COMPARATOR
Intervention: STn linked to KLH with DETOX-B adjuvant, 100 micrograms, subcutaneous injection at weeks 0, 2, 5, and 9, without low-dose cyclophosphamide (CTX, 300 mg m-2) pretreatment.
Number of subjects: 23
Study: 1294055

Group type: EXPERIMENTAL
Intervention: Coumarin (5,6 benzo‐[alpha]‐pyrone, 56 BaP) and oxerutins (HR, O(beta‐hydroxy‐ethyl)‐rutosides)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coumarin and oxerutins
Number of subjects: 0
Study: 6374537

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens 0.625 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens 1.25 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens <0.625 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (general)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens
Number of subjects: 0
Study: 3578861

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 57

Group type: COMPARATOR
Intervention: Halothane anesthesia
Number of subjects: 57
Study: 29471904

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT) for 6 months with pyridoxine
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 1284
Study: 27166229

Group type: EXPERIMENTAL
Intervention: SWS disruption (auditory stimuli causing SWS fragmentation)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: SWS disruption
Number of subjects: 14
Study: 24864327

Group type: EXPERIMENTAL
Intervention: Refractive Sulcoflex 653F (35 eyes)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Diffractive MS 714 PB Diff (33 eyes)
Number of subjects: 68
Study: 23690364

Group type: EXPERIMENTAL
Intervention: Training in infant nutrition guidelines for health care workers
Number of subjects: 458

Group type: COMPARATOR
Intervention: Usual practices control group
Number of subjects: 458
Study: 20142635

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 27
Study: 19128642

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (Cawthorne-Cooksey exercises, six times/day for 4 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Betahistine (24 mg/d for 1 month)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison between exercise and medication groups
Number of subjects: 38
Study: 15871016

Group type: EXPERIMENTAL
Intervention: (131)I plus lithium (group I+L)
Number of subjects: 80

Group type: COMPARATOR
Intervention: (131)I alone (group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: (131)I
Number of subjects: 80
Study: 12836801

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Educational Treatment (ET)
Number of subjects: 30
Study: 10567627

Group type: EXPERIMENTAL
Intervention: 50 microg salmeterol + 600 microg oxitropium bromide
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 50 microg salmeterol + placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo + 600 microg oxitropium bromide
Number of subjects: 32

Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 32
Study: 8881455

Group type: EXPERIMENTAL
Intervention: Patients with TPO‐Ab positivity (n = 50)
Number of subjects: 3756

Group type: EXPERIMENTAL
Intervention: Patients with low serum TSH (< 0.4 mU/l) (n = 44)
Number of subjects: 3756

Group type: EXPERIMENTAL
Intervention: Patients with TSH > 4.0 mU/l (n = 44)
Number of subjects: 3756

Group type: COMPARATOR
Intervention: Patients without thyroid abnormalities (n = 83)
Number of subjects: 3756
Study: 1810019

Group type: EXPERIMENTAL
Intervention: Naproxen 1000 mg daily for 4 days
Number of subjects: 8
Study: 6835734

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31250540

Group type: EXPERIMENTAL
Intervention: 1,000 IU/d vitamin D
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 2,000 IU/d vitamin D
Number of subjects: 84
Study: 29210505

Group type: EXPERIMENTAL
Intervention: Radiolabeled albumin applied to the nasal mucosa in CF patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Radiolabeled albumin applied to the nasal mucosa in controls
Number of subjects: 18
Study: 27387457

Group type: EXPERIMENTAL
Intervention: Educational interventions during prenatal care
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Brochure-based education provided in the hospital when the baby is born
Number of subjects: 901
Study: 24694082

Group type: EXPERIMENTAL
Intervention: Active video games intervention
Number of subjects: 322
Study: 22526478

Group type: EXPERIMENTAL
Intervention: Exercise intervention (RAE)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sedentary control (RAC)
Number of subjects: 37
Study: 20506403

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg
Number of subjects: 356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 356
Study: 17825130

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 mg/day for Week 1 followed by 20 mg/day thereafter)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Escitalopram (after randomization)
Number of subjects: 329
Study: 15741841

Group type: EXPERIMENTAL
Intervention: 1.2 g.min of maltodextrin + 0.6 g.min of fructose (MD+F)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.8 g.min of maltodextrin (MD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Plain water (control)
Number of subjects: 8
Study: 11316178

Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Antibiotics (norfloxacin and neomycin)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 9141939

Group type: EXPERIMENTAL
Intervention: Thiopental 4 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ketamine 1.5 mg/kg
Number of subjects: 40
Study: 8161723

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intermittent hemodialysis (IHD)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CVVH
Number of subjects: 22

Group type: COMPARATOR
Intervention: IHD
Number of subjects: 22
Study: 2834601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: COMPARATOR
Intervention: Indomethacin (50 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Enalapril (10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 9
Study: 30729953

Group type: EXPERIMENTAL
Intervention: Terlipressin infusion at 3 μg/kg/h, halved after arterial anastomosis and continued for 3 days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no terlipressin infusion)
Number of subjects: 86
Study: 28076335

Group type: EXPERIMENTAL
Intervention: E/C/F/TAF
Number of subjects: 1733

Group type: COMPARATOR
Intervention: E/C/F/TDF
Number of subjects: 1733
Study: 25869424

Group type: EXPERIMENTAL
Intervention: FIFA 11+ intervention (low exposure: mean = 149 ± 9 exercises/year)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: FIFA 11+ intervention (high exposure: mean = 314 ± 15 exercises/year)
Number of subjects: 23
Study: 23471131

Group type: EXPERIMENTAL
Intervention: 900‐mg phosphate diet plus lanthanum carbonate (LC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 900‐mg phosphate diet
Number of subjects: 39

Group type: COMPARATOR
Intervention: lanthanum carbonate (LC) alone
Number of subjects: 39
Study: 21455083

Group type: EXPERIMENTAL
Intervention: Haptic device (Phantom Desktop) simulating tactile elements of predefined clinical events.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Haptic rendering of bone surface, skin pop, dura pop, and subcutaneous tissue.
Number of subjects: 24
Study: 19144672

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17404783

Group type: EXPERIMENTAL
Intervention: Educational-behavioral joint protection program (4 meetings over 8 months)
Number of subjects: 85
Study: 15028362

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) switched on
Number of subjects: 10

Group type: COMPARATOR
Intervention: CRT switched off
Number of subjects: 10